Literature DB >> 9208882

Introduction: paraneoplastic syndromes.

L Nathanson1, T C Hall.   

Abstract

Entities:  

Mesh：

Year:  1997        PMID： 9208882

Source DB:  PubMed          Journal:  Semin Oncol        ISSN： 0093-7754            Impact factor:   4.929


× No keyword cloud information.
  7 in total

1.  Excessive tumor-elaborated VEGF and its neutralization define a lethal paraneoplastic syndrome.

Authors:  A K Wong; M Alfert; D H Castrillon; Q Shen; J Holash; G D Yancopoulos; L Chin
Journal:  Proc Natl Acad Sci U S A       Date:  2001-06-12       Impact factor: 11.205

Review 2.  Off-tumor target--beneficial site for antiangiogenic cancer therapy?

Authors:  Yihai Cao
Journal:  Nat Rev Clin Oncol       Date:  2010-08-03       Impact factor: 66.675

3.  Endostatin improves cancer-associated systemic syndrome in a lung cancer model.

Authors:  Xia Wang; Rui-Yu Zhan; Yu-Yi Wang; X I Yan; Dan Cao; Yan Li; Yi-Qin Wang; Feng Luo
Journal:  Oncol Lett       Date:  2015-03-17       Impact factor: 2.967

4.  Chronic monoarthritis and foot-drop as a paraneoplastic syndrome in prostate cancer.

Authors:  Senol Kobak
Journal:  Rheumatol Int       Date:  2010-07-22       Impact factor: 2.631

5.  Anti-VEGF agents confer survival advantages to tumor-bearing mice by improving cancer-associated systemic syndrome.

Authors:  Yuan Xue; Piotr Religa; Renhai Cao; Anker Jon Hansen; Franco Lucchini; Bernt Jones; Yan Wu; Zhenping Zhu; Bronislaw Pytowski; Yuxiang Liang; Weide Zhong; Paolo Vezzoni; Björn Rozell; Yihai Cao
Journal:  Proc Natl Acad Sci U S A       Date:  2008-11-18       Impact factor: 11.205

6.  KIAA0101 is associated with human renal cell carcinoma proliferation and migration induced by erythropoietin.

Authors:  Shengjun Fan; Xin Li; Lu Tie; Yan Pan; Xuejun Li
Journal:  Oncotarget       Date:  2016-03-22

7.  Paraneoplastic systemic sclerosis associated with colorectal carcinoma.

Authors:  Dominik Samotij; Joanna Maj; Adam Reich
Journal:  Reumatologia       Date:  2018-06-30
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.